XOMA (US) LLC to Webcast Analyst and Investor Event ‘Interleukin-1 Blockers: Unlocking Their Potential in Diabetes and Beyond’ On September 25

BERKELEY, Calif., Sept. 22, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that the company will host a live web cast of its analyst and investor event on September 25, 2008 at 5:00 PM Eastern.